medigraphic.com
SPANISH

Revista del Centro Dermatológico Pascua

ISSN 1405-1710 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2000, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2000; 9 (1)

Annular psoriasis. Communication of one case.

Alarcón H, Cortez B, Navarrete G
Full text How to cite this article

Language: Spanish
References: 11
Page: 11-14
PDF size: 192.66 Kb.


Key words:

Annular psoriasis.

ABSTRACT

The psoriasis is a papulosquamous skin disease, characterized by a relapsing and variable clinical features. It showed hiperqueratosis and epidermal hyperplasia. The HLA-Bw17 and HLA-B13 are histocompatibility antigens most associated. The occurrence is any age and sex. In Mexico the prevalence is 2 percent. Clinical morphology in skin lesions of psoriasis describe difference types; plaque, guttata, annular. The Skin biopsy show typical changes. The therapeutic not is specific although with goods results. Clinic case: Female 44 years old with history 18 months of evolution with dermatosis characterized by erytema, scale, liquenification and infiltrate border.


REFERENCES

  1. Perniciaro C, Gross D, White J, Adrian R. Familial Kaposi’s Sarcoma. Cutis 1996; 57: 220-222.

  2. Friedman A, Saltzman B. Clinical manifestations of classical, endemic African and Epidemic AIDS-associated Kaposi’s Sarcoma. JAAD 1990; 22: 1237-1248.

  3. Costa C, Ferchat F, Calvo F et al. Long-term Follow-up of Non-HIV Kaposi’s Sarcoma Treated with Low-dose Recombinant Interferon Alfa-2b. Arch Dermatol 1996; 132: 285-290.

  4. Aspiroz C, Saenz C. Herpes virus 8 y sarcoma de Kaposi. Piel 1997; 12: 174-177.

  5. Schwartz R, Spicer M, Thomas I, et al. Ecchymotic Kaposi’s Sarcoma. Cutis 1995; 56: 104-106.

  6. Schwartz R. Kaposi’s Sarcoma: Advances and perspectives. JAAD 1996; 34: 804-814.

  7. Witte M, Stuntz M, Witte C. Kaposi’s sarcoma: A Lymphologic Perspective. Int J Dermatol 1989; 28: 561-568.

  8. García M, García P. Tratamiento actualizado del sarcoma de Kaposi. Piel 1995: 175-185.

  9. Soriano V, Hewlett J. Etiología del Sarcoma de Kaposi. Med Clin 1991; 9: 662-667.

  10. Miralles E, Pérez B, Nuñez M et al. Low-dose Recombinant Interferon alfa-2ª treatment for Classic Kaposi’s Sarcoma. Arch Dermatol 1994; 130: 799-800.

  11. Rappsberg K, Wolff K, Stingl G. Kaposi’s Sarcoma. In: Fitzpatrick TB, Eisen AZS, Wolff K, Freedberg IM, Austen KF, eds: Dermatology in General Medicine, 5ª ed. Nueva York, McGraw-Hill, 199; 1:1195-1204.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cent Dermatol Pascua. 2000;9